Extent of the selectivity filter conferred by the sixth transmembrane region in the CFTR chloride channel pore.
Point mutations within the pore region of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel have previously been shown to alter the selectivity of the channel between different anions, suggesting that part of the pore may form an anion 'selectivity filter'. However, the full extent of this selectivity filter region and the location of anion binding sites in the pore are currently unclear. As a result, comparisons between CFTR and other classes of Cl(-) channel of known structure are difficult. We compare here the effects of point mutations at each of eight consecutive amino acid residues (arginine 334-serine 341) in the crucial sixth transmembrane region (TM6) of CFTR. Anion selectivity was determined using patch-clamp recording from inside-out membrane patches excised from transiently transfected mammalian cell lines. The results suggest that selectivity is predominantly controlled by a single site involving adjacent residues phenylalanine 337 and threonine 338, and that the selectivity conferred by this 'filter' region is modified by anion binding to flanking sites involving the more extracellular arginine 334 and the more intracellular serine 341. Other residues within this part of the pore play only minor roles in controlling anion permeability and conductance. Our results support a model in which specific TM6 residues make important contributions to a single, localized anion selectivity filter in the CFTR pore, and also contribute to multiple anion binding sites both within and on either side of the filter region.
Department of Physiology & Biophysics, Sir Charles Tupper Medical Building, Halifax, Nova Scotia, Canada.
Jyoti
J
Gupta
Paul
P
Lindsell
D000818:Animals; D000838:Anions / Q000378:metabolism; D001120:Arginine / Q000235:genetics; D002478:Cells, Cultured; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology*; D009154:Mutation; D018408:Patch-Clamp Techniques; D010539:Permeability; D017354:Point Mutation; D017434:Protein Structure, Tertiary / Q000502:physiology; D012694:Serine / Q000235:genetics; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D014162:Transfection
D000838:Anions; C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D012694:Serine; D001120:Arginine